C

CRISPR Therapeutics

509 employees

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Hematology
AAV
Immuno-Oncology
Genetics
Medical
Biopharma
Gene Editing

Date founded

2013

Funding rounds raised

Total raised

$38M

from 12 investors over 12 rounds

C

CRISPR Therapeutics raised undisclosed on December 14, 2020

Investors: Bill & Melinda Gates Foundation

C

CRISPR Therapeutics raised $38M on June 24, 2016

Investors: New Leaf Venture Partners

C

CRISPR Therapeutics raised $29M on April 30, 2015

Investors: S.R. One Ltd, Vertex Pharmaceuticals, Celgene, Abingworth and Versant Ventures

C

CRISPR Therapeutics raised $35M on April 29, 2015

Investors: Versant Ventures, Celgene, Abingworth and S.R. One Ltd

C

CRISPR Therapeutics raised $25M on April 24, 2014

Investors: Versant Ventures

FAQ